Melanie Kelly

Director Técnico/Científico/I+D en Panag Pharma, Inc. .

Health Technology

Consumer Services

Perfil

Melanie Kelly is currently the Executive Director & Member of the International Cannabinoid Research Society, Director at The Canadian Consortium for the Investigation of Cannabinoids, Professor at Dalhousie University, and Chief Scientific Officer at Panag Pharma, Inc. She was formerly the Chief Scientific Officer at Tetra Bio-Pharma, Inc.

Cargos activos de Melanie Kelly

Empresas	Cargo	Inicio
Dalhousie University	Corporate Officer/Principal	01/07/1991
International Cannabinoid Research Society	Director/Miembro de la Junta	01/07/2017
The Canadian Consortium for the Investigation of Cannabinoids	Director/Miembro de la Junta	-
Panag Pharma, Inc. Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.	Director Técnico/Científico/I+D	01/07/2014

Todos los cargos activos de Melanie Kelly

Antiguos cargos conocidos de Melanie Kelly.

Empresas	Cargo	Fin
TETRA BIO-PHARMA INC.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Melanie Kelly.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Melanie Kelly.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
TETRA BIO-PHARMA INC.	Health Technology

Empresas privadas	3
International Cannabinoid Research Society
The Canadian Consortium for the Investigation of Cannabinoids
Panag Pharma, Inc. Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.	Health Technology

Ver las conexiones de la empresa